UPR'NİN IRE1α/XBP-1 DALININ GSK2850163 ARACILI İNHİBİSYONU MEME KANSERİ HÜCRELERİNDE TAMOKSİFENE DUYARLILIĞI ARTIRIR | Zendy

AI Assistant Blog Pricing

Open Access

UPR'NİN IRE1α/XBP-1 DALININ GSK2850163 ARACILI İNHİBİSYONU MEME KANSERİ HÜCRELERİNDE TAMOKSİFENE DUYARLILIĞI ARTIRIR

Author(s) -

Yalçın Erzurumlu,

Hatice Kübra Doğan,

Deniz Çataklı

Publication year - 2022

Publication title -

ankara universitesi eczacilik fakultesi dergisi

Language(s) - Uncategorized

Resource type - Journals

eISSN - 2564-6524

pISSN - 1015-3918

DOI - 10.33483/jfpau.1129575

Subject(s) - tamoxifen , breast cancer , cancer research , cancer , carcinogen , medicine , oncology , chemistry , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.